Saxena, A.; Srinivasa, S.; Veerappan, I.; Jacob, C.; Mahaldar, A.; Gupta, A.; Rajagopal, A.
Enzobiotics—A Novel Therapy for the Elimination of Uremic Toxins in Patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial. Nutrients 2022, 14, 3804.
https://doi.org/10.3390/nu14183804
AMA Style
Saxena A, Srinivasa S, Veerappan I, Jacob C, Mahaldar A, Gupta A, Rajagopal A.
Enzobiotics—A Novel Therapy for the Elimination of Uremic Toxins in Patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial. Nutrients. 2022; 14(18):3804.
https://doi.org/10.3390/nu14183804
Chicago/Turabian Style
Saxena, Anita, Sanjay Srinivasa, Ilangovan Veerappan, Chakko Jacob, Amol Mahaldar, Amit Gupta, and Ananthasubramaniam Rajagopal.
2022. "Enzobiotics—A Novel Therapy for the Elimination of Uremic Toxins in Patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial" Nutrients 14, no. 18: 3804.
https://doi.org/10.3390/nu14183804
APA Style
Saxena, A., Srinivasa, S., Veerappan, I., Jacob, C., Mahaldar, A., Gupta, A., & Rajagopal, A.
(2022). Enzobiotics—A Novel Therapy for the Elimination of Uremic Toxins in Patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial. Nutrients, 14(18), 3804.
https://doi.org/10.3390/nu14183804